Victory Capital Management Inc. Trims Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Victory Capital Management Inc. lowered its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 31.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,143,602 shares of the company's stock after selling 519,066 shares during the period. Victory Capital Management Inc. owned 2.31% of Prestige Consumer Healthcare worth $98,315,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in PBH. Proficio Capital Partners LLC purchased a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $1,689,000. PNC Financial Services Group Inc. increased its position in Prestige Consumer Healthcare by 5.9% in the fourth quarter. PNC Financial Services Group Inc. now owns 5,276 shares of the company's stock worth $412,000 after buying an additional 296 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Prestige Consumer Healthcare by 7.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,053 shares of the company's stock worth $863,000 after buying an additional 731 shares during the last quarter. HighTower Advisors LLC increased its position in Prestige Consumer Healthcare by 89.5% in the fourth quarter. HighTower Advisors LLC now owns 31,666 shares of the company's stock worth $2,473,000 after buying an additional 14,958 shares during the last quarter. Finally, Swiss National Bank increased its position in Prestige Consumer Healthcare by 0.5% in the fourth quarter. Swiss National Bank now owns 97,500 shares of the company's stock worth $7,614,000 after buying an additional 500 shares during the last quarter. Institutional investors own 99.95% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on PBH shares. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Wall Street Zen upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Up 0.8%

Shares of PBH stock traded up $0.57 during midday trading on Friday, reaching $75.70. 419,148 shares of the stock were exchanged, compared to its average volume of 316,403. Prestige Consumer Healthcare Inc. has a 1 year low of $64.94 and a 1 year high of $90.04. The company's 50 day moving average is $82.92 and its two-hundred day moving average is $82.26. The company has a current ratio of 4.20, a quick ratio of 2.82 and a debt-to-equity ratio of 0.55. The firm has a market cap of $3.74 billion, a PE ratio of 17.65, a price-to-earnings-growth ratio of 2.25 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.02 EPS. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.